Pfizer: Safety Profile of Sasanlimab Was Generally Consistent With Known Profile of Bcg & Data Reported From Clinical Trials
輝瑞:Sasanlimab的安全性概況與已知的BcG概況及臨牀試驗中報告的數據一致。
Pfizer: Safety Profile of Sasanlimab Was Generally Consistent With Known Profile of Bcg & Data Reported From Clinical Trials
輝瑞:Sasanlimab的安全性概況與已知的BcG概況及臨牀試驗中報告的數據一致。
使用瀏覽器的分享功能,分享給你的好友吧